Rel/NF-κB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors

EMBO Journal

Volumn 18, Issue 10, 1999, Pages 2803-2811

  Bash, Judy ^a,b   Zong, Wei Xing ^a,b   Banga, Satnam ^c   Rivera, Amariliz ^b   Ballard, Dean W ^d   Ron, Yacov ^b   Gélinas, Céline ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Jagged 1; NF B; Notch; Rel; Tan 1

Indexed keywords

CELL SURFACE PROTEIN; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; MESSENGER RNA; TRANSCRIPTION FACTOR; CALCIUM BINDING PROTEIN; DNA BINDING PROTEIN; I KAPPA B; MEMBRANE PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NOTCH RECEPTOR; ONCOPROTEIN; PROTEIN; SERRATE PROTEINS; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR REL;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GENE INDUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE; MUTANT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; MUTATION; SPLEEN; T LYMPHOCYTE; TRANSACTIVATION;

B-LYMPHOCYTES; CALCIUM-BINDING PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; MEMBRANE PROTEINS; MUTATION; NF-KAPPA B; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; RECEPTORS, NOTCH; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES; TRANS-ACTIVATION (GENETICS);

EID: 0033577768     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.10.2803     Document Type: Article

References (64)

1. Aster, J., Pear, W., Hasserjian, R., Erba, H., Davi, F., Luo, B., Scott, M., Baltimore, D. and Sklar, J. (1994) Functional analysis of the TAN-I gene, a human homolog of Drosophila Notch. Cold Spring Harbor Symp. Quant. Biol., 59, 125-136.
2. Bailey, A.M. and Posakony, J.W. (1995) Suppressor of Hairless directly activates transcription of Enhancer of split complex genes in response to Notch receptor activity. Genes Dev., 9, 2609-2622.
3. Baldwin, A.S.,Jr (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol., 14, 649-681.
4. Barnes, P.J. and Karin, M. (1997) Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336, 1066-1071.
5. 1/S phase transition. Mol. Cell. Biol., 17, 6526-6536.
6. Bernard, H.U., Krammer, G. and Rowekamp, W.G. (1985) Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. Exp. Cell Res., 158, 237-243.
7. Bigas, A., Martin, D.I.K. and Milner, L.A. (1998) Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol. Cell. Biol., 18, 2324-2333.
8. Boothby, M.R., Mora, A.L., Scherer, D.C., Brockman, J.A. and Ballard, D.W. (1997) Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-κB. J. Exp. Med., 185, 1897-1907.
9. Bray, S. (1998) A Notch affair. Cell, 93, 499-503.
10. Brou, C., Logeat, F., Lecourtois, M., Vandekerckhove, J., Kourilsky, P., Schweisguth, F. and Israel, A. (1994) Inhibition of the DNA-binding activity of Drosophila Suppressor of Hairless and of its human homolog, KBF2/RBP-Jκ, by direct protein-protein interaction with Drosophila Hairless. Genes Dev., 8, 2491-2503.
11. Callard, D., Lescure, B. and Mazzolini, L. (1994) A method for the elimination of false positives generated by the mRNA differential display technique. Biotechniques, 16, 1096-1103.
12. Carrasco, D., Weih, F. and Bravo, R. (1994) Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs. Development, 120, 2991-3004.
13. Carrasco, D., Cheng, J., Lewin, A., Warr, G., Yang, H., Rizzo, C., Rosas, F., Snapper, C. and Bravo, R. (1998) Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein. J. Exp. Med., 187, 973-984.
14. Chan, Y.-M. and Jan, Y.N. (1998) Roles for proteolysis and trafficking in Notch maturation and signal transduction. Cell, 94, 423-426.
15. Chen, C. and Okayama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell. Biol., 7, 2745-2752.
16. Chu, Z.L., McKinsey, T.A., Liu, L., Gentry, J.J., Malim, M.H. and Ballard, D.W. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl Acad. Sci. USA, 94, 10057-10062.
17. Cordier, M. et al. ( 1990) Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J. Virol., 64, 1002-1013.
18. de la Pompa, J.L. et al. (1997) Conservation of the Notch signaling pathway in mammalian neurogenesis. Development, 124, 1139-1148.
19. Dou, S., Zeng, X., Cortes, P., Erdjument-Bromage, H., Tempst, P., Honjo, T. and Vales, L.D. (1994) The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor. Mol. Cell. Biol., 14, 3310-3319.
20. Ellisen, L.W., Bird, J., West, D.C., Soreng, A.L., Reynolds, T.C., Smith, S.D. and Sklar, J. (1991) TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell, 66, 649-661.
21. Fortini, M. and Artavanis-Tsakonas, S. (1994) The Suppressor of Hairless protein participates in Notch receptor signaling. Cell, 79, 273-282.
22. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551.
23. Gridley, T. (1997) Notch signaling in vertebrate development and disease. Mol. Cell. Neurosci., 9, 103-108.
24. Guan, E., Wang, J., Laborda, J., Norcross, M. Baeuerle, P.A. and Hoffman, T. (1996) T cell leukemia-associated human notch/ translocation-associated notch homologue has IκB-like activity and physically interacts with nuclear factor-κB proteins in T cells. J. Exp. Med., 183, 2025-2032.
25. Hasserjian, R.P., Aster, J.C., Davi, F., Weinberg, D.S. and Sklar, J. (1996) Modulated expression of Notch1 during thymocyte development. Blood, 88, 970-976.
26. Hsieh, J.J.-D., Henkel, T, Salmon, P., Robey, E., Peterson, M.G. and Hayward, S.D. (1996) Truncated mammalian notch 1 activates CBF1/ RBPJκ-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol. Cell. Biol., 16, 952-959.
27. Hsieh, J.J.-D., Nofziger, D.E., Weinmaster, G. and Hayward, S.D. (1997) Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation. J. Virol., 71, 1938-1945.
28. Jarriault, S., Brou, C., Logeat, F., Schroeter, E.H., Kopan, R. and Israël, A. (1995) Signaling downstream of activated mammalian Notch. Nature, 377, 355-358.
29. Jarriault, S., Le Bail, O., Hirsinger, E., Pourquié, O., Logeat, F., Strong, C.F., Brou, C., Seidah, N.G. and Israël, A. (1998) Delta-1 activation of Notch-1 signaling results in HES-1 transactivation. Mol. Cell. Biol., 18, 7423-7431.
30. Jones, P., May, G., Healy, L., Brown, J., Hoyne, G., Delassus, S. and Enver, T. (1998) Stromal expression of Jagged1 promotes colony formation by fetal hematopoietic progenitor cells. Blood, 92, 1505-1511.
31. Kim, H.K. and Siu, G. (1998) The Notch pathway intermediate HES-1 silences CD4 gene expression. Mol. Cell. Biol., 18, 7166-7175.
32. Kontgen, F., Grumont, R.J., Strasser, A., Metcaff, D., Li, R., Tarlinton, D. and Gerondakis, S. (1995) Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity and interleukin-2 expression. Genes Dev., 9, 1965-1977.
33. Kopan, R., Schroeter, E.H., Weintraub, H. and Nye, J.S. (1996) Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc. Natl Acad. Sci. USA, 93, 1683-1688.
34. Kopp, E.B. and Ghosh, S. (1995) NF-κB and rel proteins in innate immunity. Adv. Immunol., 58, 1-27.
35. Kumar, S. and Gélinas, C. (1993) IκBα-mediated inhibition of v-Rel DNA binding requires direct interaction with the RxxRxRxxC Rel/κB DNA-binding motif. Proc. Natl Acad. Sci. USA, 90, 8962-8966.
36. Larsson, C., Lardelli, M., White, I. and Lendahl, U. (1994) The human NOTCH1, 2 and 3 genes are located at chromosome positions 9q34, 1p13-p11 and 19p13.2-p13.1 in regions of neoplasia-associated translocation. Genomics, 24, 253-258.
37. Lecourtois, M. and Schweisguth, F. (1995) The neurogenic suppressor of hairless DNA-binding protein mediates the transcriptional activation of the enhancer of split complex genes triggered by Notch signaling. Genes Dev., 9, 2598-2608.
38. Li, L. et al. (1997) Alagille syndrome is caused by mutations in human jagged1, which encodes a ligand for Notch1. Nature Genet., 16, 243-251.
39. Li, L. et al. (1998) The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity, 8, 43-55.
40. Liang, P. and Pardee, A. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-971.
41. Lindsell, C.E., Shawber, C.J., Boulter, J. and Weinmaster, G. (1995) Jagged: a mammalian ligand that activates Notch1. Cell, 80, 909-917.
42. Ling, P.D., Hsieh, J.J.-D., Ruf, I.K., Rawlins, D.R. and Hayward, S.D. (1994) EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J. Virol., 68, 5375-5383.
43. Luque, I. and Gélinas, C. (1997) Rel/NF-κB and IκB factors in oncogenesis. Semin. Cancer Biol., 8, 103-111.
44. May, M.J. and Ghosh, S. (1997) Rel/NF-κB and IκB proteins: an overview. Semin. Cancer Biol., 8, 63-73.
45. + hematopoietic precursors. Blood, 83, 2057-2062.
46. Milner, L.A., Bigas, A., Kopan, R., Brashem-Stein, C., Bernstein, I.D. and Martin, D.I.K. (1996) Inhibition of granulocytic differentiation by mNotchl. Proc. Natl Acad Sci. USA, 93, 13014-13019.
47. Oda, T., Elkahloun, A.G., Meltzer, P.S. and Chandrasekharappa, S.C. (1997) Identification and cloning of the human homolog (Jag1) of the rat jagged1 gene from the Alagille syndrome critical region at 20p12. Genomics, 43, 376-379.
48. Pear, W.S., Aster, J.C., Scott, M.L., Hasserjian, R.P., Soffer, B., Sklar, J. and Baltimore, D. (1996) Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med., 183, 2283-2291.
49. Qi, H., Rand, M.D., Wu, X., Sestan, N., Wang, W., Rakic, P., Xu, T. and Artavanis-Tsakonas, S. (1999) Processing of the Notch ligand Delta by the metalloprotease Kuzbanian. Science, 283, 91-94.
50. Robey, E. (1997) Notch in vertebrates. Curr. Opin. Genet. Dev., 7, 551-557.
51. Robey, E., Chang, D., Itano, A., Cado, D., Alexander, H., Lans, D., Weinmaster, G. and Salmon, P. (1996) An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell, 87, 483-492.
52. Sasai, Y., Kageyama, R., Tagawa, Y. Shigemoto, R. and Nakanishi, S. (1992) Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev., 6, 2620-2634.
53. Schroeter, E.H., Kisslinger, J.A. and Kopan, R. (1998) Notch-1 signaling requires ligand-induced proteolytic release of intracellular domain. Nature, 393, 382-386.
54. Smith, S.D. et al. (1988) Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. Blood, 71, 395-402.
55. Tamura, K., Taniguchi, Y., Minoguchi, S., Sakai, T., Tun, T., Furukawa, T. and Honjo, T. (1995) Physical interaction between a novel domain of trie receptor Notch and the transcription factor RBP-Jκ/Su (H). Curr. Biol., 5, 1416-1423.
56. Varnum-Finney, B. et al. (1998) The Notch ligand, Jagged-1. influences the development of primitive hematopoietic precursor cells. Blood, 91, 4084-4091.
57. Wang, F., Gregory, C., Rowe, M., Rickinson, A.B., Wang, D., Birkenbach, M., Kikutani, H., Kishimoto, T. and Kieff, E. (1987) Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B cell activation antigen CD23. Proc. Natl Acad. Sci. USA, 84, 3452-3456.
58. Wang, F., Kikutani, H., Tsang, S., Kishimoto, T. and Kieff, E. (1991) Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J. Virol., 65, 4101-4106.
59. Washbum, T., Schweighoffer, E., Gridley, T., Chang, D., Fowlkes, B.J., Cado, D. and Robey, E. (1997) Notch activity influences the α/β versus γ/δ T cell lineage decision. Cell, 88, 833-843.
60. Weinmaster, G. (1997) The ins and outs of Notch signaling. Mol. Cell. Neurosci., 9, 91-102.
61. Weinmaster, G., Roberts, V.J. and Lemke, G. (1992) Notch 2: a second mammalian Notch gene. Development, 116, 931-941.
62. Whiteside, S.T. and Israël, A. (1997) IκB proteins: structure, function and regulation. Semin. Cancer Biol., 8, 75-82.
63. Wulczyn, F.G., Krappmann, D. and Scheidereit, C. (1996) The NF-κB/ Rel and IκB gene families: mediators of immune response and inflammation. J. Mol. Med., 74, 749-769.
64. Zong, W.-X., Bash, J. and Gélinas, C. (1998) Rel blocks both anti-Fas and TNFα-induced apoptosis and an intact Rel transactivation domain is essential for this effect. Cell Death Differ., 5, 963-972.